YOLFTbeta
33

Withuspharmaceutical Co.Ltd

330350 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

6,480.00KRW-220.00 (-3.28%)

Price History

Full chart

Market Stats

Previous Close6,700.00
Open6,690.00
Day Range6,450.00 – 6,700.00
52-Week Range5,910.00 – 11,950.00
Volume61.38K
Market Cap95.70B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.71
50-Day Avg7,406.40
200-Day Avg7,937.50

About

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name to WITHUS PHARMACEUTICAL Co.,LTD. in October 2007. WITHUS PHARMACEUTICAL Co.,LTD. was founded in 2004 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Dae-young Sung
  • Employees0
  • HeadquartersWithus Building, Seoul, South Korea, Korea
  • Websitehttps://www.withuspharm.com

Leadership

  • Mr. Dae-young SungCEO & Executive Director · b. 1959
  • GwangYoung KwonVP & Executive Director · b. 1961

Financials

Income Statement

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue50.95B51.73B52.39B26.22B57.42B64.68B80.12B102.72B106.44B
Growth (%)-+1.54%+1.28%-49.96%+119.02%+12.65%+23.87%+28.21%+3.62%
Cost of Revenue20.18B19.74B19.43B11.07B23.89B26.35B31.48B37.17B37.61B
Gross Profit30.76B31.99B32.97B15.15B33.52B38.34B48.64B65.55B68.83B
Gross Margin60.39%61.84%62.92%57.79%58.39%59.27%60.71%63.82%64.66%
Operating Expense19.49B21.05B23.23B13.79B28.64B33.46B40.73B60.10B63.17B
Operating Income11.28B10.93B9.74B1.36B4.89B4.88B7.91B5.46B5.66B
Operating Margin22.13%21.14%18.58%5.20%8.51%7.54%9.87%5.31%5.32%
EBITDA-----6.50B12.58B9.73B9.31B
EBITDA Margin-----10.04%15.70%9.47%8.75%
Net Income8.49B8.66B8.04B1.87B4.26B2.48B7.96B4.78B4.97B
Net Income Margin16.67%16.74%15.34%7.12%7.43%3.83%9.93%4.66%4.67%
R&D--1.51B856.35M1.42B2.36B1.87B2.30B2.59B
R&D as % of Total Revenue--2.89%3.27%2.47%3.64%2.33%2.24%2.43%
Interest Expense00367.66M148.10M323.96M390.74M596.06M814.08M714.66M
Interest Expense % of Total Revenue0.00%0.00%0.70%0.56%0.56%0.60%0.74%0.79%0.67%

Balance Sheet

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets69.02B76.28B107.01B106.18B118.98B119.39B130.78B134.69B136.64B
Total Liabilities24.92B23.85B30.25B29.30B38.07B36.36B40.50B41.57B38.64B
Total Equity44.10B52.43B76.76B76.88B80.91B83.04B90.28B93.12B98.01B
Cash1.93M480.00K25.14B15.49B520.00K644.00K9.17B679.00K17.39B
Total Debt12.99B10.23B13.37B15.02B-----
Net Debt---998.67M8.71B12.11B10.25B5.77B943.66M

Cash Flow

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow6.65B6.77B7.93B809.54M8.02B5.38B-1.24B9.63B6.78B
Investing Cash Flow-3.44B-6.07B-7.78B-19.32B-14.93B-7.89B3.22B-3.63B-
Financing Cash Flow-1.28B-1.78B19.42B-789.54M5.25B-2.31B-1.82B2.72B-
Capital Expenditure2.40B1.96B4.67B5.26B6.67B15.33B12.00B6.56B3.11B
Free Cash Flow--2.79B-3.21B-2.27B-12.44B-13.24B3.07B3.67B
Dividends Paid--3.60B3.60B422.04M632.94M01.32B-
FCF to OCF--35.25%-396.13%-28.33%-231.33%1070.41%31.85%54.07%
Dividend Paid to FCF--129.02%-112.41%-18.57%-5.09%0.00%43.00%-

Earnings

Report DateSep 30, 2020May 14, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 29, 2024May 14, 2024Jun 30, 2024Sep 30, 2024Mar 28, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------
EPS Actual80.94104.7340.0875.07103.45167.3354.6785.79-119.8259.4896.32211.49236.13152.98-20.60141.1488.97124.7598.17162.49-9.11300.89149.12
Surprise-----------------------
Timing------------Pre-marketAfter-hours--Pre-market------

Key Statistics & Ratios

Market Cap95.70B
Enterprise Value92.20B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.86
Price / Book0.91
Revenue (TTM)111.72B
Gross Profit (TTM)71.89B
EBITDA8.32B
Profit Margin7.13%
Operating Margin3.70%
Return on Equity7.96%
Return on Assets1.80%
Shares Outstanding13.20M
Shares Float6.13M
Beta0.71
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
100.00Dec 27, 2024
20231×
100.00Dec 27, 2023
20221×
48.00Dec 28, 2022
20211×
48.00Dec 29, 2021
20201×
32.00Dec 29, 2020

Stock Splits

  • Jun 11, 20213:2